Management and decision-making after implantation of a non-sterilized implant in a trauma patient.

J Hosp InfectMay 20, 2026 (epub)
Case ReportOrthopedic Surgery

L Tondeur, R Wirtz

✦ AI-curated · Sources linked

Case in brief

A trauma patient underwent surgery where a non-sterilized distal radius plate was inadvertently implanted. Following a root cause analysis, it was determined that multiple safety breaches contributed to this error. The patient was treated with antibiotics for seven days while the implant remained in place, and after four years, there was no evidence of infection.

Diagnostic / clinical pearl

Clinicians should implement standardized protocols for verifying sterility in surgical settings to prevent complications from sterility breaches.

Why it matters

This case highlights the importance of structured risk assessment and decision-making frameworks in managing sterility errors in orthopedic surgery.

Source

PubMed · PMID 42167603

Published in J Hosp Infect. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Orthopedic Surgery

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.